{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T21:57:12Z","timestamp":1767995832779,"version":"3.49.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"am","delay-in-days":352,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Clinique et Biologique"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.tracli.2024.03.002","type":"journal-article","created":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T03:40:33Z","timestamp":1709955633000},"page":"130-134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Study of the antigenic characteristics of red blood cells units and their sickle cell disease recipients and the G6PD activity of transfused red blood cells units"],"prefix":"10.1016","volume":"31","author":[{"given":"Morgane","family":"Le Gallo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Moutereau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e9lanie","family":"Gentil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"France","family":"Pirenne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tracli.2024.03.002_b0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253986","article-title":"Epidemiology and disease burden of sickle cell disease in France: a descriptive study based on a French nationwide claim database","volume":"16","author":"Leleu","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.tracli.2024.03.002_b0010","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1182\/hematology.2021000307","article-title":"Indications for transfusion in the management of sickle cell disease","volume":"2021","author":"Han","year":"2021","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.tracli.2024.03.002_b0015","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1182\/hematology.2021000306","article-title":"How to avoid the problem of erythrocyte alloimmunization in sickle cell disease","volume":"2021","author":"Pirenne","year":"2021","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.tracli.2024.03.002_b0020","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/ajh.24460","article-title":"Delayed hemolytic transfusion reaction in adult sickle-cell disease: presentations, outcomes, and treatments of 99 referral center episodes","volume":"91","author":"Habibi","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tracli.2024.03.002_b0025","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/bjh.13123","article-title":"Red blood cell alloimmunization is influenced by recipient inflammatory state at time of transfusion in patients with sickle cell disease","volume":"168","author":"Fasano","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tracli.2024.03.002_b0030","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/MOH.0000000000000546","article-title":"The cause and pathogenesis of hemolytic transfusion reactions in sickle-cell disease","volume":"26","author":"Pirenne","year":"2019","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.tracli.2024.03.002_b0035","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.tmrv.2019.09.007","article-title":"The role of complement in post-transfusion hemolysis and hyperhemolysis reaction","volume":"33","author":"Roumenina","year":"2019","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tracli.2024.03.002_b0040","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2021-149761","article-title":"Causes and circumstances of death: analysis in 266 Sickle cell adult patients","volume":"138","author":"Habibi","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2024.03.002_b0045","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1182\/bloodadvances.2019001143","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support","volume":"4","author":"Chou","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.tracli.2024.03.002_b0050","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1111\/trf.16403","article-title":"Screening of blood donors for sickle cell trait using a DNA-based approach: frequency in a multiethnic donor population","volume":"61","author":"Gowda","year":"2021","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2024.03.002_b0055","unstructured":"Transfusions de globules rouges homologues: produits, indications, alternatives. Haute Autorit\u00e9 de Sant\u00e9 n.d. https:\/\/www.has-sante.fr\/jcms\/c_1349939\/fr\/transfusions-de-globules-rouges-homologues-produits-indications-alternatives (accessed June 30, 2023)."},{"key":"10.1016\/j.tracli.2024.03.002_b0060","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/ajh.25051","article-title":"Glucose-6-phosphate-dehydrogenase deficient red blood cell units are associated with decreased posttransfusion red blood cell survival in children with sickle cell disease","volume":"93","author":"Sagiv","year":"2018","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tracli.2024.03.002_b0065","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/trf.13378","article-title":"Glucose-6-phosphate dehydrogenase activity decreases during storage of leukoreduced red blood cells","volume":"56","author":"Peters","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2024.03.002_b0070","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.bcmd.2008.12.005","article-title":"The global prevalence of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis","volume":"42","author":"Nkhoma","year":"2009","journal-title":"Blood Cell Mol Dis"},{"key":"10.1016\/j.tracli.2024.03.002_b0075","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1182\/blood-2018-02-785964","article-title":"How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions","volume":"131","author":"Pirenne","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2024.03.002_b0080","series-title":"The Blood Group Antigen FactsBook","author":"Reid","year":"2003"},{"key":"10.1016\/j.tracli.2024.03.002_b0085","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1246-7820(03)00042-9","article-title":"Particularit\u00e9s immunoh\u00e9matologiques dans les populations africaines et antillaises. Implications transfusionnelles","volume":"10","author":"Noizat-Pirenne","year":"2003","journal-title":"Transfusion Clinique et Biologique"},{"key":"10.1016\/j.tracli.2024.03.002_b0090","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1111\/trf.14282","article-title":"Red blood cell minor antigen mismatches during chronic transfusion therapy for sickle cell anemia","volume":"57","author":"Yee","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2024.03.002_b0095","doi-asserted-by":"crossref","DOI":"10.1182\/bloodadvances.2022009328","article-title":"Eleven years of alloimmunization in 6496 transfused patients with sickle cell disease in France","author":"Floch","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.tracli.2024.03.002_b0100","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1159\/000369513","article-title":"Red blood cell alloimmunization in sickle cell disease: listen to your ancestors","volume":"41","author":"Campbell-Lee","year":"2014","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.tracli.2024.03.002_b0105","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1537-2995.2012.03765.x","article-title":"Frequency of glucose-6-phosphate dehydrogenase-deficient red blood cell units in a metropolitan transfusion service","volume":"53","author":"Francis","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2024.03.002_b0110","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/trf.16806","article-title":"Glucose-6-phosphate dehydrogenase deficiency is more prevalent in Duffy-null red blood cell transfusion in sickle cell disease","volume":"62","author":"Yee","year":"2022","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2024.03.002_b0115","article-title":"Glucose-6-phosphate dehydrogenase deficiency and sickle cell trait among prospective blood donors: a cross-sectional study in Berekum","volume":"2016","author":"Adu","year":"2016","journal-title":"Ghana Adv Hematol"},{"key":"10.1016\/j.tracli.2024.03.002_b0120","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3324\/haematol.2019.224709","article-title":"Hemolytic transfusion reactions in sickle cell disease: underappreciated and potentially fatal","volume":"105","author":"Thein","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.tracli.2024.03.002_b0125","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/tme.12871","article-title":"Randomised controlled trial of glucose-6-phosphate dehydrogenase deficient versus non-deficient red blood cell transfusion in patients with hypoproliferative anaemia","volume":"32","author":"Krajibthong","year":"2022","journal-title":"Transfus Med"},{"key":"10.1016\/j.tracli.2024.03.002_b0130","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1172\/JCI133530","article-title":"Donor glucose-6-phosphate dehydrogenase deficiency decreases blood quality for transfusion","volume":"130","author":"Francis","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.tracli.2024.03.002_b0135","unstructured":"World Health Organization. Blood Donor Selection: Guidelines on Assessing Donor Suitability for Blood Donation 2012. WHO: Geneva n.d."}],"container-title":["Transfusion Clinique et Biologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782024000405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782024000405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T01:17:20Z","timestamp":1721438240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1246782024000405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1246782024000405"],"URL":"https:\/\/doi.org\/10.1016\/j.tracli.2024.03.002","relation":{},"ISSN":["1246-7820"],"issn-type":[{"value":"1246-7820","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Study of the antigenic characteristics of red blood cells units and their sickle cell disease recipients and the G6PD activity of transfused red blood cells units","name":"articletitle","label":"Article Title"},{"value":"Transfusion Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tracli.2024.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Soci\u00e9t\u00e9 fran\u00e7aise de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}